Home » DSM, CRUCELL SIGN LICENSE AGREEMENT WITH FERRING ON PER.C6 VACCINE TECHNOLOGY
DSM, CRUCELL SIGN LICENSE AGREEMENT WITH FERRING ON PER.C6 VACCINE TECHNOLOGY
Crucell said it and its PER.C6 technology contract manufacturer DSM Biologics signed a commercial licensing agreement with Ferring Pharmaceutical. The deal allows Ferring to use the PER.C6 cell line in the production of a specific therapeutic protein in the women's healthcare sector. The agreement is the second of its kind with Ferring, a Scandinavia-based biopharmaceutical company.
Forbes (http://www.forbes.com/home/feeds/afx/2005/12/21/afx2406528.html)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May